As a matter of fact, even though modern insulin analogs have a low immunogenicity, insulin antibodies may sometimes be detected in patients receiving insulin therapy, but these antibodies are rarely capable of causing hyperglycemia or hypoglycemia. This evidence concerns the gene INS and Hypoglycemia.